CORDSTIM-VLUNCT07449988
Modified Platform Trial Assessing Multiple Umbilical Cord-based CAMPs and SOC v SOC Alone in the Treatment of Hard-to-Heal VLUs
At risk: Primary completion moved at least 4 months later.
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
Version history last read from ClinicalTrials.gov on Aug 30, 2026. The record was updated there on Nov 20, 2026; versions filed since then are not listed here yet.
All 1 version: 1 with changes below. See every version on ClinicalTrials.gov ↗
- Minor Primary completion pushed from Jul 2029 to Dec 2029
- Study completion pushed from Sep 2029 to Apr 2030
- Study First Submitted
- Minor: routine updates
Endpoints
Primary
Secondary (5)
Arms and interventions
Standard of care will be cleaning, debridement, ulcer moisture balance, and compression therapy.
Corplex P (and alternate brand names Allacor P and Theracor P) is a dehydrated human umbilical cord-based particulate device.
Theracor is a dehydrated human umbilical cord-based sheet device.
Other: Standard of Care (SOC)
Devices: Corplex P, Theracor